{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:48:32Z","timestamp":1792648112057,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","award":["CIFMS-2021-12M-5-015"],"award-info":[{"award-number":["CIFMS-2021-12M-5-015"]}],"id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jbc.2025.110942","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T09:59:02Z","timestamp":1763373542000},"page":"110942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Selective peptide\u2013guided transcytosis enhances extracellular vesicle\u2013mediated siRNA delivery across the blood\u2013brain barrier"],"prefix":"10.1016","volume":"302","author":[{"given":"Jingwen","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110942_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1600-6143.2004.00530.x","article-title":"RNA interference: a potent tool for gene-specific therapeutics","volume":"4","author":"Ichim","year":"2004","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jbc.2025.110942_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2025.110942_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","article-title":"RNA interference (RNAi)-Based therapeutics: delivering on the promise?","volume":"56","author":"Bobbin","year":"2016","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110942_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jbc.2025.110942_bib5","first-page":"3","article-title":"Structure and function of the blood-brain barrier (BBB)","volume":"2273","author":"Benz","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110942_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2025.110942_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0271678X17740031","article-title":"Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier","volume":"38","author":"Haqqani","year":"2018","journal-title":"J. Cerebr. Blood F Met."},{"key":"10.1016\/j.jbc.2025.110942_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin-receptor monoclonal-antibody undergoes high-affinity binding to human brain capillaries in-Vitro and rapid transcytosis through the blood-brain-barrier in-Vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharmaceut Res."},{"key":"10.1016\/j.jbc.2025.110942_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","article-title":"Selective transport of an antitransferrin receptor antibody through the blood-brain-barrier invivo","volume":"259","author":"Pardridge","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2025.110942_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","article-title":"Caveolin, a protein-component of caveolae membrane coats","volume":"68","author":"Rothberg","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110942_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.conb.2018.12.014","article-title":"Transcytosis at the blood-brain barrier","volume":"57","author":"Ayloo","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jbc.2025.110942_bib12","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.1038\/ncomms9244","article-title":"dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis","volume":"6","author":"Lim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110942_bib13","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","article-title":"Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia","volume":"35","author":"Tu","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110942_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2025.110942_bib15","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.1038\/srep17543","article-title":"Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110942_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates machado-joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7ao","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jbc.2025.110942_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbc.2025.110942_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/1061186X.2019.1567737","article-title":"Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells","volume":"27","author":"Huey","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jbc.2025.110942_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrmicro2395","article-title":"A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins","volume":"8","author":"Salinas","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2025.110942_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110942_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"Aaps J."},{"key":"10.1016\/j.jbc.2025.110942_bib22","doi-asserted-by":"crossref","first-page":"1257-+","DOI":"10.1038\/s41551-022-00938-7","article-title":"Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood-brain barrier in rodents and primates","volume":"6","author":"Yao","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jbc.2025.110942_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/IJN.S154458","article-title":"Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells","volume":"13","author":"Liang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jbc.2025.110942_bib24","article-title":"Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma","volume":"34","author":"Wu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jbc.2025.110942_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2018.09.015","article-title":"A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy","volume":"289","author":"De Jong","year":"2018","journal-title":"J. Controlled Rel."},{"key":"10.1016\/j.jbc.2025.110942_bib26","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.1073\/pnas.97.24.13003","article-title":"The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters","volume":"97","author":"Wender","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110942_bib27","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.12659\/MSM.915251","article-title":"LaSota strain expressing the rabies virus glycoprotein (rL-RVG) suppresses gastric cancer by inhibiting the alpha 7 nicotinic acetylcholine receptor (\u03b17 nAChR)\/Phosphoinositide 3-Kinase (PI3K)\/AKT pathway","volume":"25","author":"Bu","year":"2019","journal-title":"Med. Sci. Monitor."},{"key":"10.1016\/j.jbc.2025.110942_bib28","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75 receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jbc.2025.110942_bib29","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","article-title":"Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus","volume":"17","author":"Tuffereau","year":"1998","journal-title":"Embo J."},{"key":"10.1016\/j.jbc.2025.110942_bib30","doi-asserted-by":"crossref","first-page":"134434","DOI":"10.1016\/j.neulet.2019.134434","article-title":"Nicotinic acetylcholine receptor at vertebrate motor endplates: endocytosis, recycling, and degradation","volume":"711","author":"Rudolf","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2025.110942_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/cells10020358","article-title":"The metabolic stability of the nicotinic acetylcholine receptor at the neuromuscular junction","volume":"10","author":"Valenzuela","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110942_bib32","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.33549\/physiolres.933975","article-title":"Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells","volume":"67","author":"B\u00f6hmov\u00e1","year":"2018","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jbc.2025.110942_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.chembiol.2012.05.022","article-title":"Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm","volume":"19","author":"Appelbaum","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2025.110942_bib34","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1039\/D0BM00427H","article-title":"An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells","volume":"8","author":"Ye","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jbc.2025.110942_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/mt.2010.254","article-title":"Microvesicle-mediated RNA molecule delivery system using monocytes\/macrophages","volume":"19","author":"Akao","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2025.110942_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2012-01-407106","article-title":"AngiomiR-126 expression and secretion from circulating CD34 and CD14 PBMCs: role for proangiogenic effects and alterations in type 2 diabetics","volume":"121","author":"Mocharla","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:03:08Z","timestamp":1773889388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825027942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0021925825027942"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110942","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective peptide\u2013guided transcytosis enhances extracellular vesicle\u2013mediated siRNA delivery across the blood\u2013brain barrier","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110942"}}